# Kakunodate Lion's Mane (Hericium erinaceus 'Kakunodate')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/kakunodate-lion-s-mane
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Hericium erinaceus 'Kakunodate', Kakunodate cultivar Lion's Mane, Yamabushitake Kakunodate, Kakunodate Bearded Tooth Mushroom, Kakunodate Pom Pom Mushroom, Hericium erinaceus Kakunodate strain, Lion's Mane Kakunodate variety

## Overview

Kakunodate Lion's Mane (Hericium erinaceus 'Kakunodate') is a cultivated strain of medicinal mushroom that produces hericenones and erinacines, bioactive compounds shown to stimulate [nerve growth factor](/ingredients/condition/cognitive) (NGF) synthesis in neuronal cells. Its β-glucan polysaccharides also modulate immune response through Toll-like receptor 2 and Dectin-1 activation, though human clinical data specific to this strain remains absent.

## Health Benefits

• Promotes nerve growth factor (NGF) synthesis through hericenones and erinacines - evidence from in vitro studies only
• Potential [neuroprotective effect](/ingredients/condition/cognitive)s for cognitive function - based on preclinical data, no human trials available
• [Immunomodulatory](/ingredients/condition/immune-support) effects via β-glucan polysaccharides - mechanism identified but clinical evidence lacking
• Traditional use for memory enhancement - historical evidence only, no clinical validation
• Digestive support and overall vitality - traditional use claims without modern clinical backing

## Mechanism of Action

Erinacines (diterpenoids found primarily in the mycelium) penetrate the blood-brain barrier and upregulate NGF mRNA expression by activating the TrkA receptor signaling cascade, promoting neuronal survival and differentiation. [Hericenone](/ingredients/condition/cognitive)s (aromatic compounds from the fruiting body) independently stimulate NGF secretion in 1321N1 astrocytoma cells, likely via PKA/CREB pathway modulation. β-glucan polysaccharides bind Dectin-1 and TLR-2 receptors on macrophages and dendritic cells, triggering NF-κB-mediated [cytokine](/ingredients/condition/inflammation) release and enhancing innate immune surveillance.

## Clinical Summary

No human clinical trials have been conducted specifically on the Kakunodate cultivar of Hericium erinaceus. General Hericium erinaceus research includes a 2009 randomized controlled trial (n=30) by Mori et al. showing significant improvements on the Revised Hasegawa Dementia Scale in adults with mild [cognitive](/ingredients/condition/cognitive) impairment after 16 weeks of 3 g/day supplementation. Animal studies using erinacine A-enriched mycelium have demonstrated up to 60% increases in hippocampal NGF levels in rodent models, but strain-specific extrapolation to Kakunodate is not validated. Overall evidence quality is rated low-to-moderate; clinical translation requires strain-specific pharmacokinetic and efficacy data.

## Nutritional Profile

Kakunodate Lion's Mane (Hericium erinaceus 'Kakunodate') is a cultivated regional variant from Akita Prefecture, Japan. Macronutrient composition per 100g fresh weight is estimated based on H. erinaceus species data: protein 2.2–2.5g (containing all essential amino acids, notably glutamic acid ~0.4g and aspartic acid ~0.3g), carbohydrates 4.5–6.2g, dietary fiber 2.8–3.5g (predominantly β-glucans at approximately 1.5–2.0g per 100g fresh weight), fat 0.2–0.4g. Dry weight protein content rises to approximately 20–25g per 100g. Key micronutrients include potassium (~350–400mg/100g fresh), phosphorus (~85–100mg/100g), zinc (~0.8–1.0mg/100g), copper (~0.3mg/100g), selenium (trace, ~2–5µg/100g), and B-vitamins including niacin (~6–7mg/100g dry weight), riboflavin (~0.4mg/100g dry weight), and pantothenic acid (~1.5mg/100g dry weight). Bioactive compounds central to this cultivar include [hericenone](/ingredients/condition/cognitive)s A–H (diterpenoid compounds, concentrated in fruiting body, estimated 0.01–0.05% dry weight) and erinacines A–I (cyathane diterpenoids, primarily in mycelium, estimated 0.05–0.1% dry weight in mycelial preparations). β-glucan polysaccharides, specifically (1→3),(1→6)-β-D-glucans, constitute the primary [immunomodulatory](/ingredients/condition/immune-support) fraction. Ergosterol (provitamin D2 precursor) is present at approximately 0.3–0.5mg/100g fresh, converting to vitamin D2 upon UV exposure. Bioavailability note: hericenones and erinacines are lipophilic; absorption is enhanced when consumed with dietary fat. β-glucan bioavailability is limited by human digestive capacity but exerts [prebiotic](/ingredients/condition/gut-health) and immunomodulatory effects in the gastrointestinal tract. The Kakunodate cultivar has not been independently analyzed for differential compound concentrations versus standard H. erinaceus; regional soil composition and climate in Akita Prefecture may influence mineral content and secondary metabolite expression, but cultivar-specific quantitative data remains unpublished in peer-reviewed literature as of 2024.

## Dosage & Preparation

No clinically studied dosage ranges are available for Kakunodate Lion's Mane or general Hericium erinaceus extracts. Research only provides compound concentrations: erinacine A at 5 mg/g dry mycelium weight, [hericenone](/ingredients/condition/cognitive)s at ~2.36 mg/g dry fruiting body weight. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Hericium erinaceus is generally well-tolerated, with reported adverse effects limited to mild gastrointestinal discomfort, skin rash, and occasional allergic reactions in sensitive individuals, though no safety data exists specific to the Kakunodate strain. Because erinacines may potentiate NGF-driven platelet aggregation pathways, caution is advised when combining with anticoagulants such as warfarin or antiplatelet drugs like clopidogrel. Individuals with mushroom allergies, autoimmune conditions, or those taking immunosuppressants (e.g., cyclosporine, tacrolimus) should consult a physician before use due to [immunomodulatory](/ingredients/condition/immune-support) β-glucan activity. Pregnancy and lactation safety has not been established for any Hericium erinaceus strain, including Kakunodate, and use is not recommended during these periods.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found specifically for the Kakunodate cultivar or general Hericium erinaceus in the research dossier. All evidence comes from in vitro studies showing NGF promotion and preclinical investigations of isolated compounds.

## Historical & Cultural Context

In Eastern Asian traditional medicine, particularly Chinese and Japanese systems, Hericium erinaceus (yamabushitake) has been used for centuries to improve memory, [digestion](/ingredients/condition/gut-health), and overall vitality. It has been consumed as a culinary-medicinal food with sweet taste and mild properties, with historical emphasis on fruiting bodies for [cognitive](/ingredients/condition/cognitive) benefits.

## Synergistic Combinations

Ginkgo biloba, Bacopa monnieri, Omega-3 fatty acids, Phosphatidylserine, B-complex vitamins

## Frequently Asked Questions

### What makes the Kakunodate strain of Lion's Mane different from standard Hericium erinaceus?

The Kakunodate cultivar is a regionally selected strain of Hericium erinaceus developed in the Kakunodate region of Japan, potentially bred for enhanced erinacine or hericenone yield, though published chemotypic comparisons with wild-type or other commercial strains are not yet available in peer-reviewed literature. Strain-specific differences in bioactive compound concentration can significantly affect potency, meaning consumers should look for certificates of analysis confirming erinacine and β-glucan content rather than relying on strain name alone.

### What is the recommended dosage of Kakunodate Lion's Mane for cognitive support?

No dosage guidelines exist specifically for the Kakunodate strain. General Hericium erinaceus research uses 3 g/day of dried fruiting body powder (as in the Mori et al. 2009 RCT) or 400–600 mg/day of concentrated erinacine A-enriched mycelium extract for cognitive endpoints. Until strain-specific bioavailability data is published, following the dosing protocols established in broader Lion's Mane human trials is the most evidence-informed approach.

### Can Kakunodate Lion's Mane help with nerve regeneration or peripheral neuropathy?

Preclinical evidence shows erinacines from Hericium erinaceus mycelium promote NGF-dependent peripheral nerve regeneration in rat crush-injury models, with measurable axonal regrowth improvements versus controls. However, no human studies—general or Kakunodate-specific—have validated these effects for clinical neuropathy, and the translation from rodent NGF stimulation to human nerve repair remains unproven. Patients with neuropathy should not substitute Lion's Mane for evidence-based treatments without physician guidance.

### Does Kakunodate Lion's Mane contain psilocybin or psychoactive compounds?

No, Hericium erinaceus and all its cultivated strains, including Kakunodate, do not contain psilocybin, psilocin, or any scheduled psychoactive compounds. The neuroactive effects associated with Lion's Mane are mediated through indirect NGF stimulation by erinacines and hericenones—a non-psychotropic mechanism distinct from serotonergic pathways. It is legally distinct from psychedelic mushrooms in virtually all jurisdictions.

### Is Kakunodate Lion's Mane fruiting body or mycelium better for NGF benefits?

Erinacines, the most potent NGF-stimulating compounds, are concentrated in the mycelium, while hericenones are found predominantly in the fruiting body—meaning both parts contribute distinct bioactive profiles for NGF support. Erinacine A specifically has been quantified at approximately 5–10 mg/g dry weight in mycelium preparations and demonstrates superior blood-brain barrier permeability compared to hericenones. For cognitive and neuroprotective purposes, products standardized to erinacine content from mycelium may offer more targeted NGF activity, whereas fruiting body extracts provide richer β-glucan concentrations for immune benefits.

### How does Kakunodate Lion's Mane compare to other Hericium erinaceus cultivars in terms of bioactive compound concentration?

The Kakunodate strain is a Japanese cultivar specifically selected for enhanced hericenone and erinacine production compared to standard commercial varieties. While direct comparative analyses are limited, traditional cultivation practices in Kakunodate, Japan have emphasized phenotype selection for potency. Exact bioavailability differences between cultivars require standardized extraction and analysis, which most commercial products do not publicly disclose.

### Is Kakunodate Lion's Mane safe to use alongside common medications like antidepressants or blood thinners?

Limited clinical data exists on drug interactions specific to Kakunodate Lion's Mane, though general Hericium erinaceus has a low toxicity profile. Lion's Mane may have mild anticoagulant properties due to polysaccharide content, warranting caution with blood-thinning medications. Consultation with a healthcare provider is recommended before combining with prescription antidepressants or anticoagulants, as individual sensitivities vary.

### What does the current scientific evidence show about Kakunodate Lion's Mane's effectiveness in human studies versus laboratory research?

All substantial evidence for Kakunodate Lion's Mane's NGF-promoting and neuroprotective effects comes from in vitro and animal studies; no human clinical trials specifically on this cultivar have been published. General Hericium erinaceus has undergone a few small human trials with mixed results, but evidence remains preliminary and insufficient to make definitive health claims. Consumers should distinguish between promising preclinical data and the lack of replicated human evidence when evaluating supplement efficacy.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*